Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: Stage II of a randomized, controlled multicenter trial

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 1, 2009, Pages 37-49

  Pohl, Marcus ^a   Mayr, Peter ^b   Mertl Roetzer, Marion ^c   Lauster, Frank ^c   Haslbeck, Manfred ^d   Hipper, Beate ^e   Steube, Diethard ^c   Tietjen, Monika ^f   Eriksen, Jan ^g   Rahlfs, Volker W ^h  

^a Klinik Bavaria in Kreischa GmbH   (Germany)

^b Diabetology   (Germany)

^c Neurological Hospital   (Germany)

^d INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^e MEDIAN Kliniken GmbH   (Germany)

^f Fresenius Kabi Deutschland GmbH   (Germany)

^g HERNING HOSPITAL   (Denmark)

^h IDV   (Germany)

Author keywords

Blood glucose; Carbohydrates; Diabetes mellitus; Enteral nutrition; Glycosylated hemoglobin A; Insulin

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARBOHYDRATE; CHROMIUM; DOCOSAHEXAENOIC ACID; FISH OIL; FLAVONOID; GLUCOSE; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; INSULIN ACTRAPHANE 30; INSULIN ACTRAPHANE 70; LONG ACTING INSULIN; MONOUNSATURATED FATTY ACID; NITROGEN DERIVATIVE; PROFIL II 40; RECOMBINANT HUMAN INSULIN; SHORT ACTING DRUG; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ANEMIA; ARTICLE; ASPIRATION PNEUMONIA; BODY WEIGHT; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN INJURY; CAUSE OF DEATH; CLINICAL EVALUATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT INFECTION; DIABETIC PATIENT; DIARRHEA; DIET RESTRICTION; DISEASE CLASSIFICATION; DIVERTICULITIS; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; DYSPHAGIA; ENTERIC FEEDING; EPILEPSY; FEEDING BEHAVIOR; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART VENTRICULAR FLUTTER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INSULIN BLOOD LEVEL; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOSE FEEDING; PATIENT COMPLIANCE; PATIENT SAFETY; PERITONITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEPSIS; STROKE; TRAUMATIC BRAIN INJURY; TUBE FEEDING; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIET, CARBOHYDRATE-RESTRICTED; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; FOOD, FORMULATED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED;

EID: 60149104696     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108324582     Document Type: Article

References (51)

1. Hogan P., Dall T., Nikolov P. ; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003 ; 26: 917-932.
2. U.S. Department of Health and Human Services. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, GA: Centers for Disease Control and Prevention ; 2005.
3. Elia M., Ceriello A., Laube H., Sinclair AJ, Engfer M., Stratton RJ Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes. Diabetes Care. 2005 ; 28: 2267-2279.
4. Coursin DB, Connery LE, Ketzler JT Perioperative diabetic and hyperglycemic management issues. Crit Care Med. 2004 ; 32 (4 Suppl). S116 - S125.
5. Umpierrez GE, Isaacs SD, Bazargan N., You X., Thaler LM, Kitabchi AE Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002 ; 87: 978-982.
6. Jones BJ, Stratton R., Holden C., Micklewright A., Glencourse C., Russel C. Trends in Artificial Nutritional Support in the UK 2000-2003: Annual Report of the British Artificial Nutrition Survey (BANS). Redditch, UK: BAPEN; 2005.
7. Boucher JL, Swift CS, Franz MJ, et al. Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. J Am Diet Assoc. 2007 ; 107: 105-111.
8. American Diabetes Association. Nutrition recommendations and interventions for diabetes-2006. Diabetes Care. 2006 ; 29: 2140-2157.
9. Van den Berghe G., Wouters PJ, Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003 ; 31: 359-366.
10. Van den Berghe G., Wouters PJ, Weekers F., et al. Intensive insulin therapy in the critically ill patients. New Engl J Med. 2001 ; 345: 1359-1367.
11. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005 ; 26: 650-661.
12. Coulston AM Enteral nutrition in the patient with diabetes mellitus. Curr Opin Clin Nutr Metab Care. 2000 ; 3: 11-15.
13. American Diabetes Association. Postprandial blood glucose. Diabetes Care. 2001 ; 24: 775-778.
14. Franz MJ, Bantle JP, Beebe CA, et al. Nutrition principles and recommendations in diabetes. Diabetes Care. 2004 ; 27 (Suppl 1). S36 - S46.
15. Schafer RG, Bohannon B., Franz MJ, et al. Diabetes nutrition recommendations for health care institutions. Diabetes Care. 2004 ; 27 (Suppl 1). S55 - S57.
16. Wright J. Total parenteral nutrition and enteral nutrition in diabetes. Curr Opin Clin Nutr Metab Care. 2000 ; 3: 5-10.
17. American Diabetes Association. Nutrition recommendations and interventions for diabetes. Diabetes Care. 2007 ; 30: S48 - S65.
18. Fürst P. Consensus Roundtable on Nutrition Support of Tube-Fed Patients with Diabetes, 28 February-1 March, 1998, Chicago, Illinois, USA. Introduction. Clin Nutr. 1998 ; 17 (suppl 2). 3-6.
19. Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis. 2004 ; 14: 373-394.
20. Ghosh D., Bhattacharya B., Mukherjee B., et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem. 2002 ; 13: 690-697.
21. Cefalu WT, Hu FB Role of chromium in human health and in diabetes. Diabetes Care. 2004 ; 11: 2741-2751.
22. Ryan GJ, Wanko NS, Redman AR, Cook CB Chromium as adjunctive treatment for type 2 diabetes. Ann Pharmacother. 2003 ; 37: 876-885.
23. Vega-Lopez S., Devaraj S., Jialal I. Oxidative stress and antioxidant supplementation in the management of diabetic cardiovascular disease. J Investig Med. 2004 ; 52: 24-32.
24. Pohl M., Mayr P., Mertl-Roetzer M., et al. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr. 2005 ; 59: 1-12.
25. Bauer P., Kohne H. Evaluation of experiments with adaptive interim analyses. Biometrics. 1994 ; 50: 1029-1041.
26. Commission of the European Communities. Reports of the Scientific Committee for Food. Luxembourg: Commission of the European Communities ; 1993.
27. European Agency for the Evaluation of Medicinal Products (EMEA). ICH Topic E9, Statistical Principles for Clinical Trials. Step 4, Consensus Guideline. CPMP/ICH/363/96. London, UK: EMEA ; 1998.
28. Wei LJ, Lachin JM Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc. 1984 ; 79: 653-661.
29. Lachin JM Some large-sample distribution-free estimators and tests for multivariate partially incomplete data from two populations. Stat Med. 1992 ; 11: 1151-1170.
30. Colditz GA, Miller JN, Mosteller F. Measuring gain in the evaluation of a medical technology. Int J Technol Assess Health Care. 1988 ; 4: 637-642.
31. Kieser M., Bauer P., Lehmacher W. Inference on multiple endpoints of Bauer and Koehne. Biom J. 1999 ; 41: 261-277.
32. Masur H. Skalen und Scores in der Neurologie. Stuttgart, Germany: Thieme; 2000.
33. Roth EJ, Lovell L., Harvey RL, Bode RK, Heinemann AW Stroke rehabilitation: indwelling urinary catheters, enteral feeding tubes, and tracheostomies are associated with resource use and functional outcomes. Stroke. 2002 ; 33: 1845-1850.
34. Hofman Z., van Drunen JD, de Later C., Kuipers H. The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes. Eur J Clin Nutr. 2004 ; 58: 1553-1556.
35. Malmberg K., Ryden L., Hamsten A., Herlitz J., Waldenstrom A., Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J. 1996 ; 17: 1337-1344.
36. Coulston AM Clinical experience with modified enteral formulas for patients with diabetes. Clin Nutr. 1998 ; 17 (suppl 2). 46-56.
37. Borges VC Specialized enteral formulae for diabetic patients. Nutrition. 2003 ; 19: 196-198.
38. Wright J. Effect of high-carbohydrate versus high-monounsaturated fatty acid diet on metabolic control in diabetes and hyperglycemic patients. Clin Nutr. 1998 ; 17 (suppl 2). 35-45.
39. Muls E. Nutrition recommendations for the person with diabetes. Clin Nutr. 1998 ; 17 (suppl 2). 18-25.
40. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr. 1998 ; 67 (3 Suppl). 577S - 582S.
41. Rabinovitz H., Friedensohn A., Leibovitz A., Gabay G., Rocas C., Habot B. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int J Vitam Nutr Res. 2004 ; 74: 178-182.
42. Vincent JB Recent developments in the biochemistry of chromium(IIII). Biol Trace Elem Res. 2004 ; 99: 1-16.
43. Biesalski HK, Böhles H., Esterbauer H., et al. Antioxidant vitamins in prevention. Clin Nutr. 1997 ; 16: 151-155.
44. Bonnefont-Rousselot D. The role of antioxidant micronutrients in the prevention of diabetic complications. Treat Endocrinol. 2004 ; 3: 41-52.
45. Guerrero-Romero F., Rodriguez-Moran M. Complementary therapy for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res. 2005 ; 36: 250-257.
46. Dickinson PJ, Carrington AL, Frost GS, Boulton AJ Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev. 2002 ; 18: 260-272.
47. Montori VM, Farmer A., Wollan PC, Dinneen SF Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care. 2000 ; 23: 1407-1415.
48. Farmer A., Montori V., Dinneen S., Clar C. Fish oil in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2001 ;(3). CD003205.
49. Nettleton JA, Katz R. n-3 Long chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc. 2005 ; 105: 428-440.
50. Craig LD, Nicholson S., SilVerstone FA, Kennedy RD Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition. 1998 ; 14: 529-534.
51. Leon-Sanz M., Garcia-Luna PP, Sanz-Paris A., et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). JPEN J Parenter Enteral Nutr. 2005 ; 29: 21-29.